Tuesday, 12 February 2013

Porto poster: alemtuzumab improves disability

#MSBlog: Alemtuzumab increases your chances of sustained or confirmed disability improvement compared to interferon-beta.

"Apologies for putting this poster up so late; it is from the Neuroimmunology Meeting in Porto a few weeks ago. I simply forgot. Its subject matter is self-explanatory!"

CoI: multiple

1 comment:

Please note that all comments are moderated and any personal or marketing-related submissions will not be shown.